Table 1.
Previously identified breast cancer survival genes in cancer-related pathways
| Pathway | Nearest gene | References |
|---|---|---|
| DNA repair | XRCC1, XRCC2, XRCC3, RAD51B, LIG4, ERCC2 | [6,28-32] |
| Cell cycle control | CCND1, CCND3, PRKAG2, TP53, SIPA1, FGFR2, PPP2R2B | [28,33-38] |
| Matrix metalloproteinases | MMP7, MMP8, MMP2, SERPINE1, TIMP-3 | [23,40-44] |
| Immune and drug response, metabolism | Il-10, IL-6, IL-21, MPO, GSTP1, COMT, CYP19A1, CYP1A1, SULT1E1, NEF2L2, TLR4, SLC28A3, CD24, CD44, NQO1 | [14,22,24,45-57] |
| Tumour progression | NOS3, VEGF, NME1, SELE, GNAS1, ZFP36, TGF | [58-64] |
| Vitamin D receptors | RXRA, VDR | [65,66] |
| Miscellaneous | TOX3, MTHFR, COX11, OCA2, PLAUR. | [4,7,34,65,67] |
NB: the genes mentioned here are the candidate genes listed in the previous publications or are the nearest gene to the single nucleotide polymorphism (SNP) and are not necessarily the genes on which the SNPs have a functional effect.